Company intelligence / Profile preview

Fertin Pharma

Vejle, Syddanmark, Denmark

Ownership: Private
Employees: ~1000
Development stage: Commercial

Overview

Fertin Pharma does not run its own clinical trials or develop proprietary drugs; instead it develops and manufactures commercialized oral/intraoral dosage forms for pharmaceutical/nutraceutical clients. Its technologies are widely used in marketed products globally—especially medicated chewing gums for nicotine replacement therapy. It holds over 500 patents related to oral delivery systems.

Therapeutic areas: GastroenterologyPulmonologyPsychiatryImmunologyOtherNeurology
Modalities: Small moleculeBiologicDevice
Industry: Contract Manufacturing Organization

Partnerships

Works with leading global pharmaceutical and nutraceutical companies as contract partners; specific names generally confidential but includes major pharma/consumer health brands.

Beyond the preview

Go deeper on Fertin Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fertin Pharma.

Explore the full profile